• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮康唑对大鼠舌背念珠菌病损的治疗效果

Resolution of candidal lesions of the dorsal rat tongue by ketoconazole.

作者信息

Allen C M, Rossie K M, Haring J I, Beck F M

机构信息

Ohio State University, College of Dentistry, Columbus 43210.

出版信息

J Oral Pathol. 1988 Apr;17(4):158-63. doi: 10.1111/j.1600-0714.1988.tb01517.x.

DOI:10.1111/j.1600-0714.1988.tb01517.x
PMID:3139852
Abstract

The purpose of this study was to determine whether the mucosal alterations of the dorsal rat tongue produced by Candida albicans infection were reversible upon treatment with the antifungal drug ketoconazole. Following experimentally-produced infection, 17 rats showed clinical evidence of persistent lesions over a period of 20 weeks. Eight of these animals were then treated with ketoconazole daily for 2 weeks (20 mg/kg/day). Appropriate non-infected controls and ketoconazole-only controls were also maintained. Five weeks after the ketoconazole treatment, all animals were killed and the dorsal tongues evaluated clinically and histologically. Control groups showed no abnormalities. Of the 8 animals in the treated-lesion group, all showed lesional resolution, while only 2 of the 9 animals in the untreated-lesion group showed resolution of their lesions (p = 0.002). These findings indicate that the epithelial changes produced by this candidal isolate for this period of time are reversible.

摘要

本研究的目的是确定白色念珠菌感染所致大鼠舌背黏膜改变在用抗真菌药物酮康唑治疗后是否可逆。在实验性感染后,17只大鼠在20周的时间里出现了持续性病变的临床证据。其中8只动物随后每天接受酮康唑治疗2周(20毫克/千克/天)。还设立了适当的未感染对照组和仅使用酮康唑的对照组。酮康唑治疗5周后,所有动物均被处死,并对舌背进行临床和组织学评估。对照组未显示异常。在治疗病变组的8只动物中,所有动物的病变均得到消退,而在未治疗病变组的9只动物中,只有2只动物的病变得到消退(p = 0.002)。这些发现表明,在此时间段内该念珠菌分离株所引起的上皮变化是可逆的。

相似文献

1
Resolution of candidal lesions of the dorsal rat tongue by ketoconazole.酮康唑对大鼠舌背念珠菌病损的治疗效果
J Oral Pathol. 1988 Apr;17(4):158-63. doi: 10.1111/j.1600-0714.1988.tb01517.x.
2
The histology of chronic candidal infection of the rat's tongue.
J Pathol. 1974 Jun;113(2):97-100. doi: 10.1002/path.1711130205.
3
Clinical, histologic and scanning electron microscopic study of the development of chronic candidiasis of the rat tongue.
J Oral Pathol Med. 1989 Jul;18(6):352-9. doi: 10.1111/j.1600-0714.1989.tb01565.x.
4
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.GM237354(一种索拉菌素衍生物)在免疫抑制大鼠实验性口腔念珠菌病中的抗真菌疗效。
Antimicrob Agents Chemother. 2001 Apr;45(4):1008-13. doi: 10.1128/AAC.45.4.1008-1013.2001.
5
Susceptibility to ketoconazole of Candida albicans strains from sequentially followed HIV-1 patients with recurrent oral candidosis.对连续随访的复发性口腔念珠菌病HIV-1患者分离的白色念珠菌菌株的酮康唑敏感性
Mycoses. 1992 Jan-Feb;35(1-2):53-6. doi: 10.1111/j.1439-0507.1992.tb00819.x.
6
Chronic mucocutaneous candidiasis treated with ketoconazole (Nizoral).用酮康唑(里素劳)治疗慢性黏膜皮肤念珠菌病。
Tandlaegebladet. 1985 Oct;89(18):674-8.
7
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.氟康唑与酮康唑治疗大鼠腭部念珠菌病的比较。
J Med Vet Mycol. 1989;27(2):63-70. doi: 10.1080/02681218980000101.
8
The histology of prolonged candidal infection of the rat's tongue.
J Oral Pathol. 1975 Dec;4(6):330-9. doi: 10.1111/j.1600-0714.1975.tb01750.x.
9
Differences in mucosal reaction related to Candida albicans isolates.
J Oral Pathol. 1987 Feb;16(2):89-93. doi: 10.1111/j.1600-0714.1987.tb00693.x.
10
Influence of tetracycline on number and size of candidal lesions of the dorsal rat tongue.四环素对大鼠舌背部念珠菌病损数量和大小的影响。
Prog Clin Biol Res. 1985;181:283-5.

引用本文的文献

1
Experimental oral candidiasis in animal models.动物模型中的实验性口腔念珠菌病。
Clin Microbiol Rev. 2001 Apr;14(2):398-429. doi: 10.1128/CMR.14.2.398-429.2001.
2
Mouthwashes in the treatment of oral disease.
Drugs. 1991 Aug;42(2):171-3. doi: 10.2165/00003495-199142020-00001.